Cargando…

Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers

Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ban, Camelia R, Twigg, Stephen M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515418/
https://www.ncbi.nlm.nih.gov/pubmed/18827908
_version_ 1782158425053986816
author Ban, Camelia R
Twigg, Stephen M
author_facet Ban, Camelia R
Twigg, Stephen M
author_sort Ban, Camelia R
collection PubMed
description Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility.
format Text
id pubmed-2515418
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-25154182008-10-01 Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers Ban, Camelia R Twigg, Stephen M Vasc Health Risk Manag Review Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility. Dove Medical Press 2008-06 2008-06 /pmc/articles/PMC2515418/ /pubmed/18827908 Text en © 2008 Ban and Twigg, publisher and licensee Dove Medical Press Ltd.
spellingShingle Review
Ban, Camelia R
Twigg, Stephen M
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
title Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
title_full Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
title_fullStr Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
title_full_unstemmed Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
title_short Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
title_sort fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515418/
https://www.ncbi.nlm.nih.gov/pubmed/18827908
work_keys_str_mv AT bancameliar fibrosisindiabetescomplicationspathogenicmechanismsandcirculatingandurinarymarkers
AT twiggstephenm fibrosisindiabetescomplicationspathogenicmechanismsandcirculatingandurinarymarkers